Incorrect news on a good old trialBMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1487 (Published 20 June 2022) Cite this as: BMJ 2022;377:o1487
- J André Knottnerus, epidemiologist and emeritus professor of general practice
- Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands
As a former member of The BMJ’s editorial board, I am a big fan of its focus on sharing knowledge and expertise to improve healthcare outcomes and have contributed to this on several occasions. But I have to share a different kind of experience.
I was made aware that my group’s independently funded, primary care based, placebo controlled randomised controlled trial showing effectiveness of influenza vaccination in reducing serological influenza and influenza-like illness in older people, with a Cochrane …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.